According to the outlet, New York-based Pfizer sold over-the-counter ranitidine drugs also known as Zantac from 1998 through 2006. In 2019, a small laboratory in Connecticut found that ranitidine ...

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get ...

Pfizer had a problem. Doctors weren’t prescribing its migraine drug Nurtec because they assumed insurance coverage would be too much of a hassle. So last year the company created a phone line ...

Pharmaceuticals and life science is such a big space, whether that is in health and safety training in factories or laboratories.” For Pfizer, immersive technology is about the accessibility and ...

Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. The New York pharma is ending global development and commercialization of ...

Pfizer Inc. shares fell 2% Tuesday despite the drugmaker topping Wall Street’s revenue and profit estimates in its fourth-quarter results. Analyst firm Edward Jones expects Pfizer’s future ...

Beqvez brings an inauspicious ending to a gene therapy that got its start more than a decade ago in the labs of Spark Therapeutics in Philadelphia. Pfizer's disclosure Friday that it is ending ...

Shares of Pfizer (NYSE:PFE) have delivered negative returns since I started covering the stock and the last four months have not been great either as it is down another 12% since my previous ...

In 2007 and 2008, Holmes conducted a study for Pfizer investigating the angiogenesis ... companies reagent that is used by LabCorp and many labs across the nation called, R&D Systems VEGF ELISA.

China’s Asymchem Laboratories has agreed to take over the operation of a Pfizer UK manufacturing facility in Sandwich, Kent, safeguarding dozens of jobs. The Tianjin-headquartered contract ...

Pfizer's EPS and revenue beat my expectations, mainly due to strong sales of its anti-cancer medications. So, Xtandi sales amounted to $565 million in the fourth quarter of 2024, an increase of 79 ...